Abstract
The aim of this review is not so much to show the problem of neuroendocrine, neurophysiologic, and neurochemical mechanisms of the immune system regulation of the organism by brain (there is a great deal of literature about it), as to solve the problem of whether the brain itself is an immune organ, and also to define cellular, neurochemical, and immunological properties of the brain for its immune defense when the blood-brain barrier is not damaged in spite of the penetration of the infection to brain. The accumulated literary data on CNS interaction with the immune system, expression of several cytokines and their receptors in the neurons of human brain culture, in astrocytes and microglia, all testify to the existence of a brain immune system. Recently studies appeared on the expression of major histocompatibility complex in brain neurons. It does not exclude the possibility of expression of immunoglobulins (or immunoglobulin-like proteins) in brain cells. Data obtained by us on the biosynthesis of a number of known interleukins and new cytokines in neurosecretory neurons of hypothalamus (N.Paraventricularis and N.Supraopticus) demonstrate that neuroendocrine nuclei of the hypothalamus are the center for neuroendocrine and immune systems of brain.
Similar content being viewed by others
REFERENCES
Brightman, M. W., Ishihara, S., and Chang, L. 1995. Penetration of solutes, viruses and cells across the blood-brain barrier. Curr. Top. Microbiol. Immunol. 202:63-78.
Kreutzberg, G. W. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312-318.
Fleshner, M., Goehler, L. E., Hermann, J., Relton, J. K., Maier, S. F., and Watkin, L. R. 1995. Interleukin-lβinduced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res. Bull. 37:605-610.
Laye, S., Bluthe, R. M., Kent, S., Lombe, C., Medina, C., Parnet, P., Kelley, K., and Dantrer, R. 1995. Subdiaphragmatic vagotomy blocks induction of IL-1βmRNA in mice brain in response to peripheral LPS. Am. J. Physiol. 268(Pt2):R1327-331.
Saphir, D., Abramsky, O., Mor, G., and Ovadia, H. 1987. Multiunit electrical activity in conscious rats during on immune response. Brain Behav. Immunol. 1:40-51.
Besedovsky, H. O., del Rey, A., Da Prada, M., and Keller, H. H. 1979. Immunoregulation mediated by the sympathetic nervous system. Cell. Immunol. 48:346-355.
Dunn, A. A., Powell, M. L., Meitin, C., and Small, Jr., P. A. 1989. Virus infection as a stressor, influenza virus elevates plasma corticosterone and brain concentration of MHPG and tryptophan. Physiol. Behav. 45:591-594.
Rebar, R. W., Miyake, A., Low, T. L. K., and Goldstein, A. L. 1981. Thymosin stimualates secretion of Luteinizing hormone-releasing factor. Science 214:669-671.
Galoyan, A. A., Chailian, S. G., and Abrahamian, G. E. 1992. The role of Tβ1 in the regulation of Ca2+and calmodulin-sensitive processes (regulation of PDE activity). Neurochem. (USSR). 11:10-20.
Azakawa, H., Nagase, H., Hayashi, N., Fujwara, T., Ogawa, M., Shin, S., and Nakumura, Y. 1994. BBRG. 200:836-843.
Galoyan, A. A., Gurvits, B. Ya., Shuvalova, L. A., Davis, M. T., Shively, J. E., and Lee, T. D. 1992. A hypothalamic activator of calmodulin-dependent enzymes is thymosin β4 (1-39). Neurochem. Res. 17:773-777.
Voelter, W., Kapurniotu, A., Mihelic, M., Gurvits, B. Ya., Abrahamian, G. E., and Galoyan, A. A. 1995. The interaction of (1-4) fragment of Tβ4 with calmodulin-sensitive cAMP PDE from hypothalamus. Neurochem. Res. 20:55-59.
Galoyan, A. A. 1997. Biochemistry of Novel Cardioactive Hormones and Immunomodulators of the Functional System Neurosecretory Hypothalamus-Endocrine Heart. Nauka publishers, Moscow, Pages-240.
Galoyan, A. A. 1992. Ca-CaM replacing peptide systems of hypothalamus new level of CaM-activated enzymes regulation. Dokl. Akad. Nauk RA, 92:173-176.
Galoyan, A. A., Gurvits, B. Ya., and Sharova, N. P. 1989. Cyclic nucleotide PDE and 5'-nucleotidase: a coupled system. Neurochem. Res. 14:1213-1221.
Galoyan, A. A. and Gurvits, B. Y. 1992. The discovery of peptidyl-prolyl-cis trans isomerase in hypothalamus (its new functions). Neurochem. (USSR). 11:89-92.
Gurvits, B. Ya., Tret'akov, O. Yu., Baranova, F. S., Egorov, Ts. A., and Galoyan, A. A. 1997. On the structure and mechanisms of action of Iph-a receptor of the immunosuppressor FK506. The 2nd Meeting of the Society for Biochemistry. Moscow, Russia. Abstr. 105.
Galoyan, A. A. and Gurvits, B. Ya. 1998. Brain Iphs: peptidyl-prolyl cis-trans isomerase activity, multiple forms and immunological functions. International Symposium “Protein structure, stability and folding, fundamental and medical aspects”. Moscow, Russia.
Gurvits, B. Ya., Tret'akov, O. Yu., Baranova, F. S., Egorov, Ts. A., and Galoyan, A. A. 1997. On the structure and mechanisms of action of Iph-a receptor of the immunosuppressor FK506. The 2nd Meeting of the Society for Biochemistry. Moscow, Russia. Abstr. 105.
Galoyan, A. A. 1998. The primary structure and biochemical mechanisms of action of newly discovered immunomodulators of brain. Abstr. of the Intern. Small Conference on “Brain and Immune System”, Yerevan-Dilidjan. Neurochem. (RAS & NAS RA). 15:82-83.
Gurvits, B. Ya., Tret'yakov, O. Yu., and Galoyan, A. A. 1998. Potentiation of FK506 action on the proliferative activity of human lymphocytes in vitro by an N-terminal peptide fragment of the 12 kd FK506-binding protein. Abstr. of the Intern. Small Conference on “Brain and Immune System”, Yerevan-Dilidjan. Neurochem. (RAS & NAS RA). 15:84-85.
Simonyan, A. A., Badalyan, R. B., Simonyan, R. A., Stepanyan, R. A., and Galoyan, A. A. 1998. Regulation of ATP-ase activity in mitochondria by 1-15 and 1-9 fragments of Iph (FK-BP). Abstr. of the Intern. Small Conference on “Brain and Immune System”, Yerevan-Dilidjan. Neurochem. (RAS & NAS RA). 15:92.
Galoyan, A. A., Sahakian, S. A., and Akopian, A. 1997. A. Immunophilin (Iph) and cardioactive neurohormones of hypothalamus in Ca2+signal transduction and control of neuronal behaviour. Joint 16-the ISN and ASN Meeting, Boston. J. Neurochem. 69(suppl.):S200 C.
Gurvits, B. Ya. and Galoyan, A. A. 1995. Structure and function of immunophilin, a receptor of immunosuppressant FK-506, isolated from bovine hypothalamus. Abstr. of the 15-th ISN Meeting, Kyoto. J. Neurochem. 65(suppl.):S178D.
Gurvits, B. Ya., Gulyaeva, N. V., and Galoyan, A. A. 1995. Peptidyl-prolyl cis-trans isomerase, thymosin and superoxide dismutase in relation to immunologic functions of the nervous system. Abstr. of the 4-the IBRO World Congress of Neuroscience, Kyoto. HA3.5. 537.
Galoyan, A. A. 1995. Immunomodulators of hypothalamus: primary structure and functions. Abstract for the 3rd International Symposium on Bioorganic Chemistry. Dagomys, Russia. 6.
Gurvits, B. Ya. and Galoyan, A. A. 1993. Isolation of immunophilin, a receptor of immunodepressant FK-506, for bovine hypothalamus. Abstract of the 14-the ISN Meeting, Montpellier, P.LA2-D.
Karageuzyan, K. G., Galoyan, A. A., and Hovsepyan, L. M. 1998. Peculiarities of molecular mechanisms of action of the synthetic N-terminal fragments corresponding to immunophilin from bovine hypothalamus on qualitative and quantitative composition of phospholipids in rat brain slices and in erythrocyte membranes as well as on erythrocyte resistance to peroxidized hemolisis. Proceedings of the Intern. Small Conference on “Brain and Immune System”, Yerevan-Dilidjan. Neurochem. (RAS & NAS RA). 15:67-75.
Simonyan, M. A., Alexanian, R. A., Babaian, M. A., Simonian, R. M., and Galoyan, A. A. 1997. Level of endogene antioxidant and new prooxidant blood metelproteins under the influence of N-terminal (1-15) fragment of FK-BP 12 (immunophilin). Abstr. of the Intern. Small Conference on “Brain and Immune System”, Yerevan-Dilidjan. Neurochem. (RAS & NAS RA).
Galoyan, A. A. 1998. Brain and Immune System (Neurochemical aspects of the problem). Proceedings of the Intern. Small Conference on “Brain and Immune System”, Yerevan-Dilidjan. Neurochem. (RAS & NAS RA). 15:3-11.
Gurvits, B. Ya., Tret'akov, O. Yu. and Galoyan, A. A. 1997. Immunologically active compounds of the brain. Neurochem. (RAS & NAS RA). 14:311-313.
Alexanian, A. R., Muradian, E. G., and Galoyan, A. A. 1998. The polyfunctional nature of Immunophilins, their role in Biochemical and Physiological Processes. Proceedings of the Intern. Small Conference on “Brain and Immune System”, Yerevan-Dilidjan. Neurochem. (RAS & NAS RA). 15:29-35.
Simonyan, M. A., Babayan, M. A., Simonyan, R. M., and Galoyan, A. A. 1998. Effects of N-terminal (1-15) Immunophilin fragment on the level of antioxidant and new pro-oxidant metaloproteins from blood. Proceedings of the Intern. Small Conference on “Brain and Immune System”, Yerevan-Dilidjan. Neurochem. (RAS & NAS RA). 15:51-55.
Sewell, T. J., Lam, E., Martin, M. M., Leszyk, J., Weider, J., Calaycay, J., Groffin, P., Williams, H., Hung S., Cryan, J., Sigal W. H., and Wiederrecht, G. J. 1994. J. Biol. Chem. 2269-21094-21102.
Gurvits, B. Ya., Tretyakov, O. Yu., and Galoyan, A. A. 1998. Identification of macrophage migration inhibitory factor in bovine hypothalamus. International Symposium “Protein structure, stability and folding. Fundamental and medical aspects”. Moscow, Russia.
Thurman, G. B., Rossio, J. L., and Goldstein, A. L. 1977. Thymosin-induced enhancement of MIF production by peripheral blood lymphocytes of thymectomized guinea pigs. In: Regulation mechanismsin lymphocyte activation, ed. By D. O. Lucas. Academic Press. N.Y.P.629-631.
Galoyan, A. A., Chailian, S. G., and Abrahamian, G. E. 1992. The role of Tβ1 in the regulation of Ca2+and calmodulin-sensitive processes (regulation of PDE activity). Neurochem. (USSR). 11:10-20.
Galoyan, A. A. and Sahakian, F. M. 1971. Isolation of cor-nary vasodilating hormones from neurosecretory granules. Docl. Acad. Nauk SSSR. 201:843-845.
Kaye, J., Porcelli, S., Tite, J., Jones, B., and Janeway, C. A. Jr. 1983. Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T-cells. J. Exp. Med. 158:836-856.
Seratte, S. A., Schulof, R. S., Leondaridis, L., Goldstein, A. L., and Sztein, M. B. 1987. Modulation of human natural killer cell cytotoxic activity, lymphokine production and interleukin-2 receptor expression by thymic hormones. J. Immunol. 139: 2338-2343.
Aarden, L. A., De Groot, E. R., Schaap, O. L., and Lansdorp, P. M. 1987. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 10:1411-1416.
Ruff, M. R. and Gifford, G. E. 1980. Purification and physicochemical characterization of rabbit tumor necrosis factor. J. Immunol. 125:1671-1677.
Aloisi, F., Penna, G., Cerase, J., Iglesias, B. M., and Adorini, L. J. Immunol. 159: 1604-1613.
Virgin, H. W., Kurt-Jones, E. A., Wittenberg, G. F., and Unanue, E. R. 1985. J. Immunol. 135:37-44.
Galoyan, A. A., Aprikian, V. S., Markossian, K. A., and Gurvits, B. Ya. 1998. Neurosecretion of cytokines by magnocellular cells of hypothalamus. Neurochem. (RAS & NAS RA). 15:361-372.
Markossian, K. A., Gurvits, B. Ya., and Galoyan, A. A. 1999. Isolation and identification of novel peptides from secretory granules of neurohypophysis. Neurochem. 16:22-25.
Gyorgy, N., Mulchahey, J. J., Smyth, D. G., and Neill, J. D. 1988. The glycopeptide moiety of vasopressin-neurophysin precursor is neurohypophyseal prolactin releasing factor. Biochem. Biophys. Res. Commun. 151:524-529.
Smyth, D. G. and Massey, D. E. 1979. A new glycopeptide in pig, ox and sheep pituitary. Biochem. Biophys. Res. Commun. 87:1006-1010.
Holwerda, D. A. 1972. A glycopeptide from the posterior lobe of pig pituitaries. 2. Primary Structure. Eur. J. Biochem. 28:340-346.
Seidah, N. G., Benjannet, S., and Chretien, M. 1981. The complete sequence of a novel human pituitary glycopeptide homologous to pig posterior pituitary glycopeptide. Biochem. Biophys. Res. Comm. 100:901-907.
Aprikyan, V. S., Galoyan, A. A. 1999. Immunocorrecting properties of a new hypothalamic polypeptide at macrophage-associated bacterial dysfunctions. Medical Science of Armenia. XXXIX. 4.
Aprikian, V. S., Chailyan, S. G., and Galoyan, A. A. 2000. Hypothalamic polypeptide enhance expression of the human growth hormone in the mice fibroblastes cultures. J. Neurochem. (RAS & NAS RA). In press.
Aprikyan, V. S. and Galoyan, A. A. 1999. Immunoprotective properties of a new hypothalamic polypeptide in bacterial pathologies. Med. Sci. Armen. XXXIX. 2:23-30.
Aprikyan, V. S. and Galoyan, A. A. 1999. Antibacterial activity of a new hypothalamic polypeptide. Docl. Acad. Nauk. RA. 4.
Davtyan, T. K., Muradyan, E. B., Avanessian, L. A., Alexanyan, Yu. T., Petrossyan, H. H., and Galoyan, A. A. 1998. The influence of new biologically active hypothalamic polypeptides on Interleukin-2-dependent functions of human lymphocytes in culture. Neurochem. (RAS & NAS RA) 15:45-50.
Galoyan, A. A., Kipriyan, T. K., Sarkissian, J. S., Sarkissian, E. J., Grigorian Y. Kh., Andreasian, A. S., and Chavushyan E. A. 2000. The protection of snake venom (Vipera raddei Boettger 1898) neuronal injury by the new hypothalamic neurohormone. Neurochem. Res. 25:791-800.
Galoyan, A. A., Terio, N., Berg, M. J., and Marks, N. 2000. Effects of proline-rich polypeptide (PRP) derived from neurophysin-II on caspases of murine neuroblastoma: evidence for caspase-2 and-6 activation. J. Neurochem. (RAS & NAS RA). (in press).
Neuman, H., Cavalie, A., Jenne, D. E., and Wekerle, H. 1995. Induction of MHC class genes in neurons. Science 269: 549-552.
Neuman, H., Boucraut, J., Hahnel, C., Misgeld, T., and Wekerle, H. 1996. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur. J. Neurosci. 8:2582-2590.
Neuman, H. and Wekerle, H. 1998. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J. Neuropathol. Exp. Neurolog. 57:1-9
Kurschner, C. and Yuzaki, M. 1999. Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein. J. Neurosci. 7770-80.
Eizenberg, O., Faber-Elman, A., Lotan, M., and Schwartz, M. 1995. Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes. J. Neurochem. 64:5. 1928-1936.
Lapchak, P. A. 1992. A role of interleukin-2 in the regulation of striatal dopaminergic function. NeuroReport. 3:165-168.
Bindoni, M., Perciavalle, V., Beretta, S., Belluardo, N., and Diamanstein, T. 1988. Interleukin 2 modifies the bioelectricactivity of some neurosecretory nuclei in the rat hypothalamus. Brain Res. 462:10-14.
McCann, S. M., Karanth, S., Kamat, A., Les Dees, W., Lyson, K., Gimeno, M. and Pettori, V. 1994. Induction by cytokines of the pattern of pituitary hormone secretion in infection. Neuroimmunomodulation 1:2-13.
Whittington, R. and Faulds, D. 1993. Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 46:446-514.
Denicoff, K. D., Durkin, T. M., Lotze, M. T., Quinlan, P. E., Davis, C. L., Listwak, S. J., Rosenberg, S. A., and Rubinow, D. R. 1989. The neuroendocrine effects of interleukin-2 treatment. J. Clin. Endocrinol. Metab. 69:402-410.
Raber, J. and Bloom, F. E. 1994. IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. J. Neurosci. 14:6187-6195.
Caraceni, A., Martini, C., Belli, F., Mascheroni, L., Rivoltini, L., Arienti, F., and Cascinelli, N. 1993. Neuropsychological and neurophysiological assesstment of the central effects of interleukin-2 administration. Eur. J. Cancer. 29A:1266-1269.
Karanth, S. and McCann, S. M. 1991. Anterior pituitary hormone control by interleukin-2. Proc. Natl. Acad. Sci. USA 88: 2961-2965.
Hanisch, U.-K. and Quirion, R. 1996. Interleukin-2 as a neuroregulatory cytokine. Brain Res. Rev. 21:246-284.
Carrieri, P. B., Maiorino, A., Provitera, V., Soscia, E., and Parrella, O. 1992. Cytokines in the pathogenesis of multiple sclerosis. Acta Neurol. Napoli. 14:333-341.
McGeer, P. L. and McGeer, E. G. 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21: 195-218.
Schulte, H. M., Bamberger, C. M., Elsen, H., Herrmann, G., Bamberger, A. M., and Barth, J. 1994. System of interleukin-1αand interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormones in humans. Eur. J. Clin. Invest. 24:773-777.
Alonso, R., Chaudieu, I., Diorio, J., Krishnamurthy, A., Quirion, R., and Boksa, P. 1993. Interleukin-1-modulates evoked release of [3H] dopamine in rat cultured mesencephalic cells. J. Neurochem. 61:1284-1290.
Hanisch, U.-K., Seto, D., and Quirin, R. 1993. Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. J. Neurosci. 13:3368-3374.
Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., and Greenberg, A. H. 1994. Cytokinespecific central monoamine alterations induced by interleukin-1,-2 and-6. Brain Res. 643:40-49.
Qiu, Y., Peng, Y., and Wang, J. 1996. Immunoregulatory role of neurotransmitters. Adv. Neuroimmunol. 6:223-231.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Galoyan, A. Neurochemistry of Brain Neuroendocrine Immune System: Signal Molecules. Neurochem Res 25, 1343–1355 (2000). https://doi.org/10.1023/A:1007656431612
Issue Date:
DOI: https://doi.org/10.1023/A:1007656431612